In recent years, growing evidence has suggested the involvement of GnRH receptor-activating autoantibodies in the pathogenesis of PCOS, similar to what is observed in functional autoantibody diseases [71]. The gene discussed is GNRHR; the disease is polycystic ovary syndrome.